Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,830
Closed -$234K 101
2024
Q2
$234K Buy
1,830
+218
+14% +$28.1K 0.04% 88
2024
Q1
$213K Buy
+1,612
New +$199K 0.04% 91
2023
Q4
Sell
-2,313
Closed -$239K 86
2023
Q3
$239K Buy
2,313
+47
+2% +$5.07K 0.06% 76
2023
Q2
$262K Buy
2,266
+175
+8% +$19.9K 0.07% 69
2023
Q1
$222K Buy
2,091
+274
+15% +$29.6K 0.06% 70
2022
Q4
$202K Buy
+1,817
New +$186K 0.06% 73

Other funds holding MRK

Peninsula Wealth's MRK Position: Q3 2024 in Review

Peninsula Wealth sold out of Merck (MRK) in Q3 2024, closing a stake of 1,830 shares — an estimated $234K sold.

Peninsula Wealth first reported a position in MRK in Q4 2022 and held it in 6 quarters. The position peaked at $262K in Q2 2023. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Peninsula Wealth reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Peninsula Wealth sold 1,830 Merck shares in Q3 2024, an estimated $234K.
  • Peninsula Wealth first reported a position in Merck in Q4 2022 and held it in 6 quarters.
  • Peninsula Wealth's Merck position peaked at $262K in Q2 2023.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Peninsula Wealth's 13F filing for Q3 2024, filed 14 Nov 2024.